Selected article for: "active disease and acute respiratory sars syndrome"
Author: ter Meulen, Jan; Bakker, Alexander BH; van den Brink, Edward N; Weverling, Gerrit J; Martina, Byron EE; Haagmans, Bart L; Kuiken, Thijs; de Kruif, John; Preiser, Wolfgang; Spaan, Willy; Gelderblom, Hans R; Goudsmit, Jaap; Osterhaus, Albert DME
Title: Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
  • Cord-id: y83lg07p
  • Document date: 2004_6_26
    • ID: y83lg07p
    Snippet: SARS coronavirus continues to cause sporadic cases of severe acute respiratory syndrome (SARS) in China. No active or passive immunoprophylaxis for disease induced by SARS coronavirus is available. We investigated prophylaxis of SARS coronavirus infection with a neutralising human monoclonal antibody in ferrets, which can be readily infected with the virus. Prophylactic administration of the monoclonal antibody at 10 mg/kg reduced replication of SARS coronavirus in the lungs of infected ferrets
    Document: SARS coronavirus continues to cause sporadic cases of severe acute respiratory syndrome (SARS) in China. No active or passive immunoprophylaxis for disease induced by SARS coronavirus is available. We investigated prophylaxis of SARS coronavirus infection with a neutralising human monoclonal antibody in ferrets, which can be readily infected with the virus. Prophylactic administration of the monoclonal antibody at 10 mg/kg reduced replication of SARS coronavirus in the lungs of infected ferrets by 3·3 logs (95% Cl 2·6–4·0 logs; p<0·001), completely prevented the development of SARS coronavirus-induced macroscopic lung pathology (p=0·013), and abolished shedding of virus in pharyngeal secretions. The data generated in this animal model show that administration of a human monoclonal antibody might offer a feasible and effective prophylaxis for the control of human SARS coronavirus infection.

    Search related documents:
    Co phrase search for related documents
    • abolish shedding and lung pathology: 1
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • absence presence and lung lesion: 1, 2, 3
    • absence presence and lung pathology: 1
    • absence presence and lung sample: 1
    • absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory syndrome and lung homogenate: 1, 2
    • acute respiratory syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung lesion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and lung manifestation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and lung pathology: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung sample: 1, 2, 3, 4
    • acute respiratory syndrome and lung surface area: 1
    • acute respiratory syndrome and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lymphocyte infiltration: 1, 2, 3, 4, 5, 6
    • lung tissue and lymphocyte infiltration: 1, 2, 3